Thyroid Pharmacology (review with handout) Flashcards
Thyroid hormone absoprtion
- best in ileum, colon (bioavail 65%-85% T4, 95% T3)
- Modified by binding-proteins (T4), food, intestinal flora
- absorp impaired in severe myxedema
Levothyroxine (when.how to take)
Drugs that can impair absorp
-take on empty stomach w/ water 30-60 mins before breakfast or 4 hours after last meal in evening
Drugs that impair levo:
Metal ions (antacids, Ca and iron supp)
Ciprofloxacin, bile acid sequestrants
Avoid interaction by spacing levothyroxine dose 2 hrs before or 4-6 hours after interacting drug
thyroid hormone distrib
-bound to plasma in TBG
-only unbound active
Changes in TBG levels or binding affinity will affect total, not free lvls
-Drugs that increase binding:
estrogens/SERMS (others too)
-Drugs that decrease binding:
anticonvulsants (phenytoin, carbamazepine) and others
Activation of thyroid hormones
T4 to T3 is active hormone
- T3 utilized by peripheral tissues derived from T4 deiodination in liver via 5’ deiodinase
- T3 in brain and pit derived by intracellular deiodination
Activating enzyme inhibited by: Drugs glucocorticoids beta blockers amiodarone propylthiouracil and Conditions: acute and chronic illness caloric deprivation Malnutrition Fetal/neonatal period
Metabolic clearance rates
increased in hyperthyroidism and CYP450 induction, decreased by hypothyroidism
-half-life of T4 = 7 days, T3= 1 day (degree of protein binding is major difference)
Long T1/2 of T4– once daily dose Cp fluctation about 10%
Tx of hypothyroidism
Levothyroxine (T4)
Resolution of sx begins in 2-3 weeks:
6-8 weeks to reach steady state
USE CAUTION in starting therapy if cardiac disease exists
Tx of hypothyr in pregnancy
Req increased dose due to:
increased levels of TBG (via increased estrogen) decreases free T4, T3 no intact gland to increase production
-increased placental metabolism of T4-T3
Monitor TSH levels
Avg dose increase by 25%
Myxedema Coma
End state of untreated hypothyroidism:
Acute medical emergency (decreased Na, decreased glucose, hypothermai, shock death)
Large doses of T4: IV loading w/ IV daily dosing followed
Hydrocortisone to prevent adrenal crisis as T4 may increase metab
Advantages of Levothyroxine
Stability, content uniformity, lack of allergenic protein (vs Thyroid USP)
Low cost
Once-daily dosing – minimal fluctuation in Cp peak-trough
Can be given orally or IV
*advise to use the SAME T4 product (brand or generic) throughout tx
Relative to levothyroxine T4, T3 has
- greater oral bioavail
- greater affinity for thyroid hormone receptors (10X)
- greater potential for CV SE
- is more expensive
Liothyronine
synthetic T3
-well absorbed, rapid action, shorter duration of effect allows quicker dosage adjustments (1-2 weeks intervals)
NOT good for routine replacement due to short t1/2 and high cost
Avoid with pts with cardiac disease
May increase risk of osteoporosis
Liotrix
4:1 mixture of T4 and T3
No advantage since T4 conversion to T3 in periphery results in near normal ratio
More expensive
Rarely required, not recommended
May increase incidence of low TSH concentrations and increase markers of bone turnover
Thyroid USP
-Dessicated porcine thyroid extract containing T3 and T4
Absorption characteristics and half-lives of T4 and T3 are same as in non-combination products
Disadvantages include:
Variable T4/T3 ratio and content; unexpected toxicities (T3:T4 ratio higher than generally desirable)
Protein antigenicity
Product instability
Less desirable than levothyroxine - current recommendation is use in hypothyroidism should be avoided***
Adverse Rxns
- toxicity related to plasma hormone level, equivalent to signs and sx of hyperthyroidism
- Children: restlessness, insomnia, accelerated bone maturation
- Adults: anxiety, heat intolerance, palpitations-tachycardia, tremors, weight loss, diarrhea
- Sympathetic overactivity: can precipitate arrhythmias, angina, or MI in patients with cardiac disease
Drug interaction with thyroid hormones:
Increased adrenergic effect of sympathomimetics: Epi or decongestants (pseudoephedrine - phenylephrine)
General Treatment of Graves Disease (hyperthyroidism)
-interfering w/ hormone production– synthesis inhibitors:
thionamides
iodides
Modifying Tissue response: symptomatic improvement:
beta blockers
corticosteroids
Glandular destruction:
radioactive iodine
surgery